サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1504304

ビタミンK2の世界市場：機能別、製品タイプ別、応用形態別、由来別、用途別、地域別-2029年までの予測

Vitamin K2 Market by Product Type, Source, Form, Application, Function - Global Forecast to 2029
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 228 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
ビタミンK2の世界市場：機能別、製品タイプ別、応用形態別、由来別、用途別、地域別-2029年までの予測
出版日: 2024年06月24日
発行: MarketsandMarkets
ページ情報: 英文 228 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のビタミンK2の市場規模は、2024年には1億4,000万米ドルと推定され、今後13.7%のCAGRで拡大し、2029年には2億6,500万米ドルに達すると予測されています。

ビタミンK2市場の成長は、研究開発の進歩によって推進されています。現在進行中の研究により、ビタミンK2の新たな健康効果や潜在的な用途が発見され続けており、それによりビタミンK2の魅力が拡大しています。これらの新たな利点は、より幅広い消費者層に貢献し、栄養補助食品および機能性食品分野における製品革新の新たな機会を生み出しています。

調査範囲
調査対象年 2024年～2029年
基準年 2023年
予測期間 2024年～2029年
検討単位 金額（米ドル）
セグメント別 機能別、製品タイプ別、応用形態別、由来別、用途別、地域別
対象地域 北米、欧州、アジア太平洋地域、その他の地域

さらに、市場の成長は、消費者の認識と教育の向上によって促進されます。健康団体やサプリメントメーカーが提供するキャンペーンや情報資源は、ビタミンK2の重要性に対する認識を著しく高めています。これにより、消費者の信頼が高まり、ビタミンK2強化製品の消費が増加しています。さらに、消費者が特定の健康ニーズを満たすためにオーダーメイドの栄養ソリューションを求める個別栄養化の動向は、ビタミンK2サプリメントの需要を加速させています。

この動向は、予防ヘルスケアやウェルネスに対する消費者の志向の高まりに大きく後押しされています。骨と心臓血管の健康を維持することが長期的に有益であるという認識が広まるにつれ、効果的で信頼性の高いサプリメントに対する需要が急増しています。カルシウム代謝と心血管保護に重要な役割を果たすことで知られるビタミンK2は、健康志向の消費者の間で大きな支持を集めています。

健康補助食品分野が優位に立つ主な理由の一つは、ビタミンK2の有効性を支持する科学的証拠が増えていることです。骨密度を促進し、動脈石灰化を予防することで、骨粗鬆症や心血管疾患のリスクを低減するというビタミンK2の役割が、数多くの研究で強調されています。このような利点は、これらの疾患にかかりやすい高齢者にとっては特に魅力的です。その結果、ビタミンK2サプリメントは、健康と生活の質の向上を目指す高齢者の間で人気の選択肢となっています。

当レポートでは、世界のビタミンK2市場について調査し、機能別、製品タイプ別、応用形態別、由来別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • マクロ経済指標
  • 市場力学

第6章 業界の動向

  • イントロダクション
  • サプライチェーン分析
  • バリューチェーン分析
  • 貿易分析
  • 技術分析
  • 価格分析
  • エコシステム分析
  • 顧客のビジネスに影響を与える動向/混乱
  • 特許分析
  • 2024年～2025年の主な会議とイベント
  • 規制状況
  • ポーターのファイブフォース分析
  • 主な利害関係者と購入基準
  • ケーススタディ分析
  • 投資と資金調達のシナリオ

第7章 ビタミンK2市場（機能別）

  • イントロダクション
  • 骨と心臓血管の健康
  • 血液の健康と凝固
  • 抗炎症と免疫
  • その他

第8章 ビタミンK2市場（製品タイプ別）

  • イントロダクション
  • MK-4
  • MK-7

第9章 ビタミンK2市場（応用形態別）

  • イントロダクション
  • カプセルと錠剤
  • 粉末と結晶
  • 液体

第10章 ビタミンK2市場（由来別）

  • イントロダクション
  • 天然
  • 合成

第11章 ビタミンK2市場（用途別）

  • イントロダクション
  • 医薬品
  • 機能性食品・飲料
  • 健康サプリメント

第12章 ビタミンK2市場（地域別）

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第13章 競合情勢

  • 概要
  • 主要参入企業の戦略/秘策
  • 収益分析
  • 市場シェア分析
  • 企業価値評価と財務指標
  • ブランド/製品比較分析
  • 企業評価マトリックス：主要参入企業、2023年
  • 企業評価マトリックス：スタートアップ/中小企業、2023年
  • 競合シナリオと動向

第14章 企業プロファイル

  • 主要参入企業
    • GNOSIS BY LESAFFRE（NATTOPHARMA）
    • KAPPA BIOSCIENCE AS（BALCHEM CORP.）
    • J-OIL MILLS, INC.
    • NOVOZYMES A/S
    • BASF SE
    • SUNGEN BIOSCIENCE CO.,LTD
    • VESTA NUTRA
    • RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
    • MENADIONA
    • GENOFOCUS
    • ANGELYEAST CO., LTD.
    • GENEFERM BIOTECHNOLOGY CO., LTD.
    • NAKODA CHEMICALS LTD.
    • HAIHANG INDUSTRY
    • CHEMICEA LIMITED
    • KYOWA HAKKO U.S.A., INC.
  • スタートアップ/中小企業
    • SEEBIO BIOTECH（SHANGHAI）CO.,LTD.
    • MAGNESIA GMBH
    • FALCON TRADING INTERNATIONAL
    • ABCO INDIA
    • ACT

第15章 隣接市場と関連市場

第16章 付録

目次
Product Code: FB 9049

The global vitamin K2 market is estimated to be valued at USD 140 million in 2024 and is projected to reach USD 265 million by 2029 at a CAGR of 13.7%. The growth of the Vitamin K2 market is propelled by advancements in research and development. Ongoing studies continue to uncover new health benefits and potential applications for Vitamin K2, thereby expanding its appeal. These emerging benefits contribute to a broader consumer base and create new opportunities for product innovation in the nutraceutical and functional food sectors.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product Type, Source, Form, Application, Function & Region
Regions coveredNorth America, Europe, Asia Pacific, and Rest of the World

Furthermore, market growth is facilitated by increasing consumer awareness and education. Campaigns and informational resources provided by health organizations and supplement manufacturers have significantly raised awareness about the importance of Vitamin K2. This has led to higher consumer confidence and an uptick in the consumption of Vitamin K2-enriched products. Additionally, the trend towards personalized nutrition, where consumers seek tailored dietary solutions to meet their specific health needs, has spurred demand for Vitamin K2 supplements.

"During the forecast period, the health supplements segment in applications emerges as the dominant segment in the vitamin K2 market."

This trend is largely driven by the increasing consumer inclination towards preventive healthcare and wellness. As individuals become more aware of the long-term benefits of maintaining bone and cardiovascular health, the demand for effective and reliable supplements has surged. Vitamin K2, known for its crucial role in calcium metabolism and cardiovascular protection, is gaining significant traction among health-conscious consumers.

One of the primary reasons for the dominance of the health supplements segment is the growing body of scientific evidence supporting the efficacy of Vitamin K2. Numerous studies have highlighted its role in promoting bone density and preventing arterial calcification, thereby reducing the risk of osteoporosis and cardiovascular diseases. These benefits are particularly appealing to aging populations, who are more susceptible to these conditions. As a result, Vitamin K2 supplements have become a popular choice among older adults looking to enhance their health and quality of life.

"Powder & Crystalline form is the dominant market in the vitamin K2 market."

The powder & crystalline form of Vitamin K2 is emerging as the dominant segment in the Vitamin K2 market, driven by its versatile applications and numerous advantages over other forms. This trend reflects a growing preference for powdered supplements in both the consumer and industrial markets, underscoring the convenience, stability, and efficacy that powdered Vitamin K2 offers.

The factor contributing to the dominance of the powder form in the Vitamin K2 market is its exceptional versatility. Vitamin K2 powder can be easily incorporated into a wide range of products, including dietary supplements, functional foods, and beverages. This adaptability allows manufacturers to create a diverse array of Vitamin K2-enriched products, catering to various consumer preferences and dietary needs. For example, powdered Vitamin K2 can be seamlessly blended into protein shakes, nutritional bars, dairy products, and even baked goods, making it a suitable choice for both health enthusiasts and the general population.

The break-up of the profile of primary participants in the vitamin K2 market:

  • By Company Type: Tier 1 - 35%, Tier 2 - 30%, and Tier 3 - 35%
  • By Designation: C Level - 22%, Director Level - 33%, Others - 45%
  • By Region: North America - 17%, Europe - 26%, Asia Pacific - 38%, and Rest of the World - 19%

Prominent companies include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea) among others.

Research Coverage:

This research report categorizes the vitamin K2 market by Product Type (MK-4, MK-7), Source (Natural, Synthetic), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceuticals, Functional Food & Beverages, Health Supplements), and Region (North America, Europe, Asia Pacific, and Rest of the World).

The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the vitamin K2 market. It also provides a detailed analysis of the major players in the market, including their business overview, products offered, key strategies, partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the vitamin K2 market is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall vitamin K2 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growth in health consciousness among consumers and increasing health expenditure, and Increase in research and application of vitamin K2), restraints (Inconsistency in regulatory norms governing vitamin K2, and Price volatility of raw materials), opportunities (Growing demand for natural and functional foods, Demand for personalized nutrition and tailored menaquinone products, and Untapped vitamin K2 applications), and challenges (Lack of consumer awareness regarding benefits specific to vitamin K2, and High research and development costs) influencing the growth of the vitamin K2 market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the vitamin K2 market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the vitamin K2 market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin K2 market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea), among others in the vitamin K2 market strategies. The report also helps stakeholders understand the vitamin K2 market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 UNIT CONSIDERED
    • 1.4.1 CURRENCY UNIT
    • TABLE 2 USD EXCHANGE RATES, 2020-2023
    • 1.4.2 VOLUME UNIT
  • 1.5 STAKEHOLDERS
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 VITAMIN K2 MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key insights from industry experts
      • 2.1.2.3 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOP-DOWN APPROACH
    • FIGURE 2 VITAMIN K2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • 2.2.2 SUPPLY-SIDE ANALYSIS
    • FIGURE 3 VITAMIN K2 MARKET SIZE CALCULATION: SUPPLY-SIDE ANALYSIS
    • 2.2.3 BOTTOM-UP APPROACH
    • FIGURE 4 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS AND RISK ASSESSMENT
  • 2.6 RECESSION IMPACT ANALYSIS
    • 2.6.1 RECESSION MACROINDICATORS
    • FIGURE 6 INDICATORS OF RECESSION
    • FIGURE 7 GLOBAL INFLATION RATE, 2012-2022
    • FIGURE 8 GLOBAL GROSS DOMESTIC PRODUCT, 2012-2022 (USD TRILLION)
    • FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON VITAMIN K2 MARKET
    • FIGURE 10 GLOBAL VITAMIN K2 MARKET: CURRENT FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

    • TABLE 3 VITAMIN K2 MARKET SNAPSHOT, 2024 VS. 2029
    • FIGURE 11 MK-7 SEGMENT TO HOLD LARGER MARKET SIZE IN 2024
    • FIGURE 12 POWDER AND CRYSTALLINE TO BE LARGEST APPLICATION FORM SEGMENT IN 2024
    • FIGURE 13 NATURAL SOURCE SEGMENT TO DOMINATE MARKET IN 2024
    • FIGURE 14 PHARMACEUTICALS APPLICATION SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
    • FIGURE 15 ASIA PACIFIC HELD LARGEST MARKET SHARE IN 2023

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET
    • FIGURE 16 GROWING CONSUMER PREFERENCES FOR NATURAL AND ORGANIC PRODUCTS TO DRIVE DEMAND FOR VITAMIN K2
  • 4.2 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE AND KEY COUNTRY
    • FIGURE 17 MK-7 SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2024
  • 4.3 VITAMIN K2 MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
    • FIGURE 18 US ACCOUNTED FOR LARGEST SHARE IN 2023
  • 4.4 VITAMIN K2 MARKET, BY PRODUCT TYPE AND REGION
    • FIGURE 19 MK-7 SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 VITAMIN K2 MARKET, BY APPLICATION FORM
    • FIGURE 20 POWDER AND CRYSTALLINE SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • 4.6 VITAMIN K2 MARKET, BY SOURCE
    • FIGURE 21 NATURAL SEGMENT TO ACCOUNT FOR LARGER MARKET SIZE DURING FORECAST PERIOD
  • 4.7 VITAMIN K2 MARKET, BY APPLICATION
    • FIGURE 22 HEALTH SUPPLEMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 RISING GDP AND POPULATION
    • FIGURE 23 GLOBAL POPULATION GROWTH, 1950-2050 (BILLION)
    • FIGURE 24 GDP GROWTH, 2016-2023 (USD TRILLION)
    • 5.2.2 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
    • FIGURE 25 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990-2030
    • 5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS
  • 5.3 MARKET DYNAMICS
    • FIGURE 26 VITAMIN K2 MARKET: MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Rising health consciousness among consumers
    • FIGURE 27 OECD HEALTH SPENDING AS SHARE OF GDP, 2017-2021
      • 5.3.1.2 Growing research and development activities
    • FIGURE 28 GLOBAL EXPANSION OF VITAMIN K2 RESEARCH OVER THREE DECADES (1990-2020)
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Inconsistency in regulatory norms
      • 5.3.2.2 Price volatility of raw materials
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Growing demand for natural and plant-based ingredients
      • 5.3.3.2 Rising need for personalized nutrition and customized products
      • 5.3.3.3 Untapped applications
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Lack of consumer awareness regarding specific health benefits
      • 5.3.4.2 High research and development costs

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 SUPPLY CHAIN ANALYSIS
    • FIGURE 29 VITAMIN K2 MARKET: SUPPLY CHAIN ANALYSIS
  • 6.3 VALUE CHAIN ANALYSIS
    • FIGURE 30 VALUE CHAIN ANALYSIS: VITAMIN K2 MARKET
    • 6.3.1 RAW MATERIAL SOURCING
    • 6.3.2 MANUFACTURING AND PROCESSING
      • 6.3.2.1 Product formulation and development
    • 6.3.3 QUALITY ASSURANCE AND CERTIFICATION
    • 6.3.4 MARKETING AND DISTRIBUTION
  • 6.4 TRADE ANALYSIS
    • 6.4.1 EXPORT SCENARIO
    • FIGURE 31 EXPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019-2023 (USD THOUSAND)
    • 6.4.2 IMPORT SCENARIO
    • FIGURE 32 IMPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019-2023 (USD THOUSAND)
    • TABLE 4 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (USD THOUSAND)
    • TABLE 5 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (TON)
    • TABLE 6 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (USD THOUSAND)
    • TABLE 7 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (TON)
  • 6.5 TECHNOLOGY ANALYSIS
    • 6.5.1 KEY TECHNOLOGY
      • 6.5.1.1 Fermentation technology
    • 6.5.2 COMPLEMENTARY TECHNOLOGY
      • 6.5.2.1 Encapsulation technology
    • 6.5.3 ADJACENT TECHNOLOGY
      • 6.5.3.1 Biotechnology
  • 6.6 PRICING ANALYSIS
    • 6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE
    • TABLE 8 AVERAGE SELLING PRICE (ASP), BY PRODUCT TYPE, 2020-2023 (USD/TON)
    • FIGURE 33 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2020-2023 (USD/TON)
    • 6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
    • TABLE 9 AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2023 (USD/TON)
  • 6.7 ECOSYSTEM ANALYSIS
    • 6.7.1 DEMAND SIDE
    • 6.7.2 SUPPLY SIDE
    • FIGURE 34 KEY PLAYERS IN VITAMIN K2 ECOSYSTEM
    • TABLE 10 VITAMIN K2 MARKET ECOSYSTEM
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 6.9 PATENT ANALYSIS
    • FIGURE 36 NUMBER OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013-2023
    • FIGURE 37 REGIONAL ANALYSIS OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013-2023
    • 6.9.1 LIST OF MAJOR PATENTS
    • TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO VITAMIN K2, 2020-2023
  • 6.10 KEY CONFERENCES AND EVENTS, 2024-2025
    • TABLE 12 VITAMIN K2 MARKET: KEY DETAILED LIST OF CONFERENCES AND EVENTS, 2024-2025
  • 6.11 REGULATORY LANDSCAPE
    • 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.11.1.1 Regulations in North America
        • 6.11.1.1.1 US
        • 6.11.1.1.2 Canada
      • 6.11.1.2 Regulations in Europe
      • 6.11.1.3 Regulations in Asia Pacific
        • 6.11.1.3.1 China
        • 6.11.1.3.2 India
  • 6.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 16 IMPACT OF PORTER'S FIVE FORCES ON VITAMIN K2 MARKET
    • FIGURE 38 PORTER'S FIVE FORCES ANALYSIS: VITAMIN K2 MARKET
    • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.12.2 BARGAINING POWER OF SUPPLIERS
    • 6.12.3 BARGAINING POWER OF BUYERS
    • 6.12.4 THREAT OF NEW ENTRANTS
    • 6.12.5 THREAT OF SUBSTITUTES
  • 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
    • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
    • 6.13.2 BUYING CRITERIA
    • FIGURE 40 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
    • TABLE 18 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
  • 6.14 CASE STUDY ANALYSIS
    • 6.14.1 ESTABLISHING DISTINCT RECOMMENDED DIETARY INTAKE TO PROMOTE HEALTHIER DIETARY CHOICES
    • 6.14.2 ENHANCING ABILITY IN NUTRACEUTICAL FORMULATIONS FOR IMPROVED QUALITY AND EFFICACY
  • 6.15 INVESTMENT AND FUNDING SCENARIO
    • FIGURE 41 INVESTMENT AND FUNDING SCENARIO, 2019-2024 (USD MILLION)

7 VITAMIN K2 MARKET, BY FUNCTION

  • 7.1 INTRODUCTION
  • 7.2 BONE AND CARDIOVASCULAR HEALTH
    • 7.2.1 COMPREHENSIVE HEALTH BENEFITS TO DRIVE MARKET
  • 7.3 BLOOD HEALTH AND CLOTTING
    • 7.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
  • 7.4 ANTI-INFLAMMATORY AND IMMUNITY
    • 7.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
  • 7.5 OTHER FUNCTIONS

8 VITAMIN K2 MARKET, BY PRODUCT TYPE

  • 8.1 INTRODUCTION
    • TABLE 19 PRODUCT TYPE: OVERVIEW
    • FIGURE 42 MK-7 SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
    • TABLE 20 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 21 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 22 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 23 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
  • 8.2 MK-4
    • 8.2.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET GROWTH
    • TABLE 24 MK-4: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 25 MK-4: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 26 MK-4: VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 27 MK-4: VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)
  • 8.3 MK-7
    • 8.3.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
    • TABLE 28 MK-7: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 29 MK-7: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 30 MK-7: VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 31 MK-7: VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)

9 VITAMIN K2 MARKET, BY APPLICATION FORM

  • 9.1 INTRODUCTION
    • FIGURE 43 POWDER AND CRYSTALLINE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 32 VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 33 VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
  • 9.2 CAPSULES AND TABLETS
    • 9.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
    • TABLE 34 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 35 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.3 POWDER AND CRYSTALLINE
    • 9.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
    • TABLE 36 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 37 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.4 LIQUIDS
    • 9.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
    • TABLE 38 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 39 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)

10 VITAMIN K2 MARKET, BY SOURCE

  • 10.1 INTRODUCTION
    • FIGURE 44 NATURAL SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
    • TABLE 40 VITAMIN K2 MARKET: BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 41 VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • 10.2 NATURAL
    • 10.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
    • TABLE 42 NATURAL: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 43 NATURAL: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 10.3 SYNTHETIC
    • 10.3.1 LOW PRODUCTION COST TO DRIVE MARKET
    • TABLE 44 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 45 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)

11 VITAMIN K2 MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 46 APPLICATION: OVERVIEW
    • FIGURE 45 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
    • TABLE 47 VITAMIN K2 MARKET: BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 48 VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.2 PHARMACEUTICALS
    • 11.2.1 RISING GOVERNMENT INVESTMENTS IN DEVELOPMENT OF NEW FORMULATIONS TO DRIVE MARKET
    • TABLE 49 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 50 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 11.3 FUNCTIONAL FOODS AND BEVERAGES
    • 11.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
    • TABLE 51 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 52 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 11.4 HEALTH SUPPLEMENTS
    • 11.4.1 INCREASED AWARENESS REGARDING ASSOCIATED HEALTH BENEFITS TO DRIVE MARKET
    • TABLE 53 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 54 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)

12 VITAMIN K2 MARKET, BY REGION

  • 12.1 INTRODUCTION
    • FIGURE 46 ITALY TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 55 VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 56 VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 57 VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 58 VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)
  • 12.2 NORTH AMERICA
    • TABLE 59 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 60 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 61 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (TON)
    • TABLE 62 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (TON)
    • TABLE 63 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 64 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 65 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 66 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 67 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 68 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 69 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 70 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 71 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 72 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
    • FIGURE 47 INFLATION IN NORTH AMERICA: COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 48 NORTH AMERICA: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.2.2 US
      • 12.2.2.1 Growing awareness regarding importance of preventive health measures to drive market
    • TABLE 73 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 74 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.2.3 CANADA
      • 12.2.3.1 Increasing focus on preventive healthcare and natural products to propel market
    • TABLE 75 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 76 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.2.4 MEXICO
      • 12.2.4.1 High prevalence of chronic lifestyle diseases to drive market
    • TABLE 77 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 78 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
  • 12.3 EUROPE
    • FIGURE 49 EUROPE: VITAMIN K2 MARKET SNAPSHOT
    • TABLE 79 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 80 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 81 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (TON)
    • TABLE 82 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (TON)
    • TABLE 83 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 84 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 85 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 86 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 87 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 88 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 89 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 90 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 91 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 92 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.3.1 EUROPE: RECESSION IMPACT ANALYSIS
    • FIGURE 50 INFLATION IN EUROPE: COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 51 EUROPE: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.3.2 GERMANY
      • 12.3.2.1 Rising focus on proactive healthcare to drive market
    • TABLE 93 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 94 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Innovative products and investments in research and development to boost market growth
    • TABLE 95 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 96 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.4 UK
      • 12.3.4.1 Rapidly aging population to propel market growth
    • TABLE 97 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 98 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.5 ITALY
      • 12.3.5.1 Evolving dietary preferences to boost market growth
    • TABLE 99 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 100 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.6 SPAIN
      • 12.3.6.1 Growing consumer interest in health supplements to propel drive demand
    • TABLE 101 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 102 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.7 REST OF EUROPE
    • TABLE 103 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 104 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 52 ASIA PACIFIC VITAMIN K2 MARKET SNAPSHOT
    • TABLE 105 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (TON)
    • TABLE 108 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (TON)
    • TABLE 109 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 112 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 113 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    • FIGURE 53 INFLATION IN ASIA PACIFIC: COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 54 ASIA PACIFIC: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.4.2 CHINA
      • 12.4.2.1 Surging use of digital media to disseminate healthcare information to propel market
    • TABLE 119 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 120 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.3 JAPAN
      • 12.4.3.1 Consumer preferences for natural healthcare solutions to boost market growth
    • TABLE 121 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 122 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.4 INDIA
      • 12.4.4.1 Strategic market penetration initiatives by various companies to drive market
    • TABLE 123 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 124 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.5 AUSTRALIA AND NEW ZEALAND
      • 12.4.5.1 Changing consumer preferences and increasing health consciousness to drive demand
    • TABLE 125 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 126 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.6 REST OF ASIA PACIFIC
    • TABLE 127 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 128 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
  • 12.5 ROW
    • TABLE 129 ROW: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 130 ROW: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 131 ROW: VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 132 ROW: VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)
    • TABLE 133 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 134 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 135 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 136 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 137 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 138 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 139 ROW: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 140 ROW: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 141 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 142 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.5.1 ROW: RECESSION IMPACT ANALYSIS
    • FIGURE 55 INFLATION IN ROW, COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 56 ROW: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.5.2 SOUTH AMERICA
      • 12.5.2.1 Collaboration among key market players to drive market growth
    • TABLE 143 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 144 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.5.3 MIDDLE EAST AND AFRICA
      • 12.5.3.1 Developing regulatory landscape to propel market growth
    • TABLE 145 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 146 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 147 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS
  • 13.3 REVENUE ANALYSIS
    • FIGURE 57 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST THREE YEARS, 2021-2023 (USD MILLION)
  • 13.4 MARKET SHARE ANALYSIS
    • FIGURE 58 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2023
    • TABLE 148 VITAMIN K2 MARKET: DEGREE OF COMPETITION
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.5.1 COMPANY VALUATION
    • FIGURE 59 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS, 2023 (USD BILLION)
    • 13.5.2 EV/EBITDA
    • FIGURE 60 EV/EBITDA OF KEY COMPANIES, 2023
  • 13.6 BRAND/PRODUCT COMPARISON ANALYSIS
    • FIGURE 61 BRAND/PRODUCT COMPARISON ANALYSIS, BY PRODUCT TYPE
    • 13.6.1 MENAQUINGOLD
    • 13.6.2 MENAQ7
    • 13.6.3 K2VITAL
    • 13.6.4 VITAMK7
    • 13.6.5 MENATTO
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • FIGURE 62 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.7.5.1 Company footprint
    • FIGURE 63 VITAMIN K2 MARKET: COMPANY FOOTPRINT
      • 13.7.5.2 Regional footprint
    • TABLE 149 VITAMIN K2 MARKET: REGIONAL FOOTPRINT
      • 13.7.5.3 Product type footprint
    • TABLE 150 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
      • 13.7.5.4 Application footprint
    • TABLE 151 VITAMIN K2 MARKET: APPLICATION FOOTPRINT
      • 13.7.5.5 Source footprint
    • TABLE 152 VITAMIN K2 MARKET: SOURCE FOOTPRINT
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • FIGURE 64 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 13.8.5 COMPETITIVE BENCHMARKING
      • 13.8.5.1 Detailed list of key startups/SMEs
    • TABLE 153 VITAMIN K2 MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2023
      • 13.8.5.2 Competitive benchmarking of key startup/SMEs
    • TABLE 154 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
  • 13.9 COMPETITIVE SCENARIO AND TRENDS
    • 13.9.1 PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 155 VITAMIN K2 MARKET: PRODUCT LAUNCHES AND DEVELOPMENTS, JANUARY 2020-JUNE 2024
    • 13.9.2 DEALS
    • TABLE 156 VITAMIN K2 MARKET: DEALS, JANUARY 2020-JUNE 2024
    • 13.9.3 EXPANSIONS
    • TABLE 157 VITAMIN K2 MARKET: EXPANSIONS, JANUARY 2020-JUNE 2024
    • 13.9.4 OTHERS
    • TABLE 158 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, JANUARY 2020 - JUNE 2024

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats)**
    • 14.1.1 GNOSIS BY LESAFFRE (NATTOPHARMA)
    • TABLE 159 GNOSIS BY LESAFFRE (NATTOPHARMA): COMPANY OVERVIEW
    • TABLE 160 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 161 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 162 GNOSIS BY LESAFFRE (NATTOPHARMA): DEALS
    • TABLE 163 GNOSIS BY LESAFFRE (NATTOPHARMA): OTHER DEALS/DEVELOPMENTS
    • 14.1.2 KAPPA BIOSCIENCE AS (BALCHEM CORP.)
    • TABLE 164 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY OVERVIEW
    • FIGURE 65 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY SNAPSHOT
    • TABLE 165 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 166 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 167 KAPPA BIOSCIENCE AS (BALCHEM CORP.): DEALS
    • TABLE 168 KAPPA BIOSCIENCE AS (BALCHEM CORP.): EXPANSIONS
    • TABLE 169 KAPPA BIOSCIENCE AS (BALCHEM CORP.): OTHER DEALS/DEVELOPMENTS
    • 14.1.3 J-OIL MILLS, INC.
    • TABLE 170 J-OIL MILLS, INC.: COMPANY OVERVIEW
    • FIGURE 66 J-OIL MILLS, INC.: COMPANY SNAPSHOT
    • TABLE 171 J-OIL MILLS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 172 J-OIL MILLS, INC.: PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 173 J-OIL MILLS, INC.: DEALS
    • 14.1.4 NOVOZYMES A/S
    • TABLE 174 NOVOZYMES A/S: COMPANY OVERVIEW
    • FIGURE 67 NOVOZYMES A/S: COMPANY SNAPSHOT
    • TABLE 175 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 176 NOVOZYMES A/S: DEALS
    • 14.1.5 BASF SE
    • TABLE 177 BASF SE: COMPANY OVERVIEW
    • FIGURE 68 BASF SE: COMPANY SNAPSHOT
    • TABLE 178 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.6 SUNGEN BIOSCIENCE CO.,LTD
    • TABLE 179 SUNGEN BIOSCIENCE CO.,LTD: COMPANY OVERVIEW
    • TABLE 180 SUNGEN BIOSCIENCE CO.,LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.7 VESTA NUTRA
    • TABLE 181 VESTA NUTRA: COMPANY OVERVIEW
    • TABLE 182 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.8 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
    • TABLE 183 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • TABLE 184 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 185 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
    • 14.1.9 MENADIONA
    • TABLE 186 MENADIONA: COMPANY OVERVIEW
    • TABLE 187 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 188 MENADIONA: PRODUCT LAUNCHES AND DEVELOPMENTS
    • 14.1.10 GENOFOCUS
    • TABLE 189 GENOFOCUS: COMPANY OVERVIEW
    • TABLE 190 GENOFOCUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 191 GENOFOCUS: PRODUCT LAUNCHES AND DEVELOPMENTS
    • 14.1.11 ANGELYEAST CO., LTD.
    • TABLE 192 ANGELYEAST CO., LTD.: COMPANY OVERVIEW
    • TABLE 193 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.12 GENEFERM BIOTECHNOLOGY CO., LTD.
    • TABLE 194 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • TABLE 195 GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.13 NAKODA CHEMICALS LTD.
    • TABLE 196 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
    • TABLE 197 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.14 HAIHANG INDUSTRY
    • TABLE 198 HAIHANG INDUSTRY: COMPANY OVERVIEW
    • TABLE 199 HAIHANG INDUSTRY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.15 CHEMICEA LIMITED
    • TABLE 200 CHEMICEA LIMITED: COMPANY OVERVIEW
    • TABLE 201 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.16 KYOWA HAKKO U.S.A., INC.
    • TABLE 202 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
    • TABLE 203 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 14.2 STARTUPS/SMES
    • 14.2.1 SEEBIO BIOTECH (SHANGHAI) CO.,LTD.
    • TABLE 204 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
    • 14.2.2 MAGNESIA GMBH
    • TABLE 205 MAGNESIA GMBH: COMPANY OVERVIEW
    • 14.2.3 FALCON TRADING INTERNATIONAL
    • TABLE 206 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
    • 14.2.4 ABCO INDIA
    • TABLE 207 ABCO INDIA: COMPANY OVERVIEW
    • 14.2.5 ACT
    • TABLE 208 ACT: COMPANY OVERVIEW
  • *Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

15 ADJACENT AND RELATED MARKETS

  • 15.1 INTRODUCTION
    • TABLE 209 ADJACENT MARKETS TO VITAMIN K2 MARKET
  • 15.2 LIMITATIONS
  • 15.3 DIETARY SUPPLEMENTS MARKET
    • 15.3.1 MARKET DEFINITION
    • 15.3.2 MARKET OVERVIEW
    • TABLE 210 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 211 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 15.4 VITAMINS MARKET
    • 15.4.1 MARKET DEFINITION
    • 15.4.2 MARKET OVERVIEW
    • TABLE 212 VITAMINS MARKET, BY REGION, 2017-2022 (USD MILLION)
    • TABLE 213 VITAMINS MARKET, BY REGION, 2023-2028 (USD MILLION)

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS